HIV & AIDS

US approves first pill to help prevent HIV

(AP) — The Food and Drug Administration on Monday approved the first drug shown to reduce the risk of HIV infection, the latest milestone in the 30-year battle against the virus that causes AIDS.

Medications

Roche probed over faulty drug-safety reporting

Swiss pharmaceutical giant Roche is under investigation over a failure to properly report adverse drug side-effects, the European Medicines Agency (EMA) said on Thursday.

Arthritis & Rheumatism

FDA panel urges approval for Pfizer arthritis drug

An advisory committee to the US Food and Drug Administration on Wednesday urged US regulators to approve a new treatment for rheumatoid arthritis made by the pharmaceutical giant Pfizer.

Medications

US watchdog warns on fitness stimulant

The US Food and Drug Administration on Friday questioned the safety of DMAA, a stimulant used in dietary supplements, alleging that marketers were illegally selling the chemical.

Medications

Supreme Court ruling supports generic drug makers

The US Supreme Court ruled Tuesday that generic drug makers can challenge big-name pharmaceutical firms in court to stop them from broadening the scope of their patent descriptions.

Medications

FDA to decide on Qnexa obesity drug in July

US regulators will decide in July whether to approve Qnexa, the first obesity drug in more than a decade, extending the initial deadline by three months, the California-based drug-maker VIVUS said.

Medications

US warns of cancer-agent in Japan weight loss pills

The US Food and Drug Administration on Tuesday warned consumers not to take a product called "Japan Rapid Weight Loss Diet Pills" because they contain a suspected cancer-causing agent.

Alzheimer's disease & dementia

Experts challenge FDA over approval for new dose of Alzheimer's drug

Approval for a new dose of a best-selling Alzheimer's drug "breached the FDA's own regulatory standard" and has led to "incomplete and distorted messages" about the drug, warn experts in the British Medical Journal today.

Health

Coke, Pepsi to drop level of 'cancer' chemical

Coca-Cola and Pepsi said Friday they have lowered levels of a chemical in caramel coloring to comply with a California law, but insisted the drinks pose no health risks and recipes will not change.

page 4 from 7